Company Filing History:
3 out of 181 
1 out of 1,198 Years Active: 2011-2023
Title: The Innovations of Teng-Kuang Yeh
Introduction
Teng-Kuang Yeh is a notable inventor based in Bellevue, WA (US). He has made significant contributions to the field of pharmaceuticals and biotechnology. With a total of 3 patents, his work focuses on innovative compounds and methods that address various medical conditions.
Latest Patents
Among his latest patents are the "CDGSH iron sulfur domain 2 activators and use thereof," which includes Isoindoline compounds and their pharmaceutical compositions. These patents also provide methods for treating Cisd2-insufficiency associated disorders and protecting against doxorubicin-induced cardiotoxicity. Additionally, he has developed Imidazol-4-one and imidazole-4-thione compounds, which are designed to treat cannabinoid receptor-mediated disorders.
Career Highlights
Teng-Kuang Yeh has worked with esteemed organizations such as the National Health Research Institutes and National Yang Ming Chiao Tung University. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Some of his notable coworkers include Yu-Sheng Chao and Ting-Fen Tsai. Their collaborative efforts have further enhanced the impact of his research and innovations.
Conclusion
Teng-Kuang Yeh's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and therapies.